AbbVie Inc.
ABBV · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $61.2B | $56.3B | +8.6% |
| Operating income | $15.1B | $9.14B | +65.0% |
| Net income | $4.19B | $4.24B | −1.2% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 3, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $17.4B | $15.8B | +10.3% |
| Operating income | $6.27B | $1.90B | +229% |
| Net income | $4.22B | $186M | +2,168% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was AbbVie's revenue in FY2025?
- $61.2B in FY2025 (Fiscal year ended Dec 31, 2025), +8.6% vs $56.3B a year earlier, per its 10-K filed Feb 2026.
- Was AbbVie profitable in FY2025?
- Yes: net income was $4.19B and operating income $15.1B in FY2025.
- What was AbbVie's revenue in Q3 2026?
- $17.4B (+10.3% vs a year earlier), per its Form 10-Q filed Nov 3, 2026.